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Background: Despite overall improvements in cardiovascular disease therapies and outcomes, lack of medication adherence remains an 
important barrier to the effective secondary prevention of atherothrombotic disease.
methods: We examined data from the prospective international Reduction of Atherothrombosis for Continued Health (REACH) Registry. Analyses 
were derived from 25,737 patients with established atherothrombotic disease who had adherence data at enrollment and at year 4. Adherence was 
defined as patients’ self-report of taking medications based on Class I ACC/AHA guidelines for secondary prevention as defined as use of all three 
classes of drugs: antiplatelet agents, statins and anti-hypertensive medications. Covariates included were demographics, region, risk factors, prior 
vascular disease and incident non-fatal events.
results: Among patients with atherothrombotic disease, 12,500 (48.6%) received all 3 classes of medications and were deemed complete 
guideline-adherent. These patients were more likely to be younger, have less polyvascular disease, be of white race and report full-time employment. 
On multivariate analyses, Hispanic and East Asian patients were less likely to be adherent as compared to Caucasians (Odds Ratios [OR]=0.72 
95% CI 0.59-0.88; OR=0.68; 95% CI 0.54-0.85, respectively). Patients who underwent coronary angioplasty or stenting during follow-up were more 
likely to be adherent (OR=2.31; 95% CI 1.86-2.85), as were patients who had a non-fatal MI during follow-up (OR=1.62; 95% CI 1.20-2.20). On the 
other hand, non-fatal stroke during follow-up was inversely associated with adherence (OR=0.81; 95% CI 0.71-0.93). Region, smoking status and 
polyvascular disease were also predictive of adherence.
conclusion: Using a large, international registry of stable outpatients with atherothrombotic disease, we found that age, region, race/ethnicity 
and incident cardiovascular events were predictive of long-term complete guideline adherence for secondary prevention. These findings suggest 
that certain patient groups such as older adults, racial/ethnic minorities, and stroke patients may benefit from targeted interventions to improve 
adherence.
